Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 396 shares at $104.28 ($41K) on 2021-04-20, disclosed to the SEC on 2021-04-21.
Scheduled sale ($41k) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RARE | SELL | 2024-03-05 | $513K | — | Filing → |
| RARE | SELL | 2023-09-06 | $228K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |